Financial Relationships between Organizations That Produce Clinical Practice Guidelines and the Biomedical Industry: A Cross-Sectional Study

English version České info

In this cross sectional study, Henry Stelfox and colleagues examine conflict of interest policies for organizations that produce clinical practice guidelines disclosing their relationships with biomedical companies.

Vyšlo v časopise: Financial Relationships between Organizations That Produce Clinical Practice Guidelines and the Biomedical Industry: A Cross-Sectional Study. PLoS Med 13(5): e32767. doi:10.1371/journal.pmed.1002029
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1002029

Souhrn

Zdroje

1. Tricoci P, Allen JM, Kramer JM, Califf RM, Smith SC Jr. Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA. 2009;301:831–841. doi: 10.1001/jama.2009.205 19244190

2. Norris SL, Holmer HK, Ogden LA, Selph SS, Fu R. Conflict of interest disclosures for clinical practice guidelines in the national guideline clearinghouse. PLoS ONE. 2012;7:e47343. doi: 10.1371/journal.pone.0047343 23144816

3. Lo B, Field MJ, editors. Conflict of interest in medical research, education, and practice. Institute of Medicine. Washington (District of Columbia): National Academies Press; 2009.

4. Norris SL, Holmer HK, Ogden LA, Burda BU. Conflict of interest in clinical practice guideline development: a systematic review. PLoS ONE. 2011;6:e25153. doi: 10.1371/journal.pone.0025153 22039406

5. Choudhry NK, Stelfox HT, Detsky AS. Relationships between authors of clinical practice guidelines and the pharmaceutical industry. JAMA. 2002;287:612–617. 11829700

6. Steinbrook R. Guidance for guidelines. N Engl J Med. 2007;356:331–333. 17251529

7. Bindslev JB, Schroll J, Gotzsche PC, Lundh A. Underreporting of conflicts of interest in clinical practice guidelines: cross sectional study. BMC Med Ethics. 2013;14:19. doi: 10.1186/1472-6939-14-19 23642105

8. Boyd EA, Akl EA, Baumann M, Curtis JR, Field MJ, Jaeschke R, et al. Guideline funding and conflicts of interest: article 4 in integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. Proc Am Thorac Soc. 2012;9:234–242. doi: 10.1513/pats.201208-057ST 23256165

9. Taylor R, Giles J. Cash interests taint drug advice. Nature. 2005;437:1070–1071. 16237402

10. Emanuel EJ, Thompson DF. The concept of conflicts of interest. In: Emanuel EJ, editor. The Oxford textbook of clinical research ethics. Oxford: Oxford University Press; 2008. pp. 758–766.

11. Thompson DF. Understanding financial conflicts of interest. N Engl J Med. 1993;329:573–576. 8336759

12. Field MJ, Lohr KN, editors. Clinical practice guidelines: directions for a new program. Institute of Medicine. Washington (District of Columbia): National Academies Press; 1990.

13. Agency for Healthcare Research and Quality. National Guideline Clearinghouse: inclusion criteria. 2014 Dec 10 [cited 19 Jan 2016]. Available: http://www.guideline.gov/about/inclusion-criteria.aspx.

14. Agency for Healthcare Research and Quality. National Guideline Clearinghouse. 2013 [cited 9 Jun2013]. Available: http://www.guideline.gov.

15. Andrews J, Guyatt G, Oxman AD, Alderson P, Dahm P, Falck-Ytter Y, et al. GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol. 2013;66:719–725. doi: 10.1016/j.jclinepi.2012.03.013 23312392

16. Jacobs AK, Anderson JL, Halperin JL, ACC/AHA Task Force Members. The evolution and future of ACC/AHA clinical practice guidelines: a 30-year journey: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Circulation. 2014;130:1208–1217. doi: 10.1161/CIR.0000000000000090 25092464

17. Guyatt GH, Oxman AD, Kunz R, Falck-Ytter Y, Vist GE, Liberati A, et al. Going from evidence to recommendations. BMJ. 2008;336:1049–1051. doi: 10.1136/bmj.39493.646875.AE 18467413

18. US Department of Health and Human Services. Approved drug products with therapeutic equivalence evaluations. 33rd ed. Washington (District of Columbia): US Department of Health and Human Services; 2013. 1346 p.

19. Council of Medical Specialty Societies. Code for interactions with companies. 2015 Apr [cited 5 May 2016]. Available: http://cmss.org/wp-content/uploads/2016/02/CMSS-Code-for-Interactions-with-Companies-Approved-Revised-Version-4.13.15-with-Annotations.pdf.

20. Baumann MH, Lewis SZ, Gutterman D. ACCP evidence-based guideline development: a successful and transparent approach addressing conflict of interest, funding, and patient-centered recommendations. Chest. 2007;132:1015–1024. 17540835

21. Burns KE, Duffett M, Kho ME, Meade MO, Adhikari NK, Sinuff T, et al. A guide for the design and conduct of self-administered surveys of clinicians. CMAJ. 2008;179:245–252. doi: 10.1503/cmaj.080372 18663204

22. Dillman DA. Mail and telephone surveys: the total design method. New York: Wiley-Interscience; 1978.

23. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–174. 843571

24. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continous outcomes. Biometrics. 1986;42:121–130. 3719049

25. Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA. 2000;283:373–380. 10647801

26. Orlowski JP, Wateska L. The effects of pharmaceutical firm enticements on physician prescribing patterns. There’s no such thing as a free lunch. Chest. 1992;102:270–273. 1623766

27. Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet. 2004;363:1341–1345. 15110490

28. Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L. Industry sponsorship and research outcome. Cochrane Database Syst Rev. 2012;12:MR000033. doi: 10.1002/14651858.MR000033.pub2 23235689

29. Licurse A, Barber E, Joffe S, Gross C. The impact of disclosing financial ties in research and clinical care: a systematic review. Arch Int Med. 2010;170:675–682.

30. Drazen JM, Van Der Weyden MB, Sahni P, Rosenberg J, Marusic A, Laine C, et al. Uniform format for disclosure of competing interests in ICMJE journals. Lancet. 2009;374:1395–1396. doi: 10.1016/S0140-6736(09)61796-7 19836071

31. International Committee of Medical Journal Editors. Author responsibilities—conflicts of interest. 2015 [cited 10 Mar 2015]. Available: http://www.icmje.org/recommendations/browse/roles-and-responsibilities/author-responsibilities—conflicts-of-interest.html

32. Association of American Medical Colleges. In the interest of the patients: recommendations for physician financial relationships and clinical decision making. 2010 Jun [cited 10 Mar 2015]. Available: https://members.aamc.org/eweb/upload/In the Interest of Patients.pdf.

33. Kuehn BM. Payments to physicians, medical schools to be illuminated under new reform law. JAMA. 2010;303:2237–2238. doi: 10.1001/jama.2010.724 20530769

34. GlaxoSmithKline. Corporate responsibility report 2013. 2013 [cited 10 Mar 2015]. Available: http://www.gsk.com/media/325170/cr-report-2013.pdf.

35. Ransohoff DF, Pignone M, Sox HC. How to decide whether a clinical practice guideline is trustworthy. JAMA. 2013;309:139–140. doi: 10.1001/jama.2012.156703 23299601

36. Loewenstein G, Sah S, Cain DM. The unintended consequences of conflict of interest disclosure. JAMA. 2012;307:669–670. doi: 10.1001/jama.2012.154 22337676

37. Krimsky S. Combating the funding effect in science: what’s beyond transparency? Stanford Law Pol Rev. 2010;21:101–123.

38. Neuman J, Korenstein D, Ross JS, Keyhani S. Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study. BMJ. 2011;343:d5621. doi: 10.1136/bmj.d5621 21990257

39. Roseman M, Turner EH, Lexchin J, Coyne JC, Bero LA, Thombs BD. Reporting of conflicts of interest from drug trials in Cochrane reviews: cross sectional study. BMJ. 2012;345:e5155. doi: 10.1136/bmj.e5155 22906823